CareDx Stock Forecast, Price & News

CareDx (NASDAQ:CDNA) Frequently Asked Questions

Is CareDx a buy right now?

6 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for CareDx in the last twelve months. There are currently 1 hold rating, 4 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" CareDx stock.
View analyst ratings for CareDx or view top-rated stocks.

How has CareDx's stock been impacted by COVID-19?

CareDx's stock was trading at $18.94 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, CDNA shares have increased by 133.4% and is now trading at $44.20.
View which stocks have been most impacted by COVID-19.

When is CareDx's next earnings date?

CareDx is scheduled to release its next quarterly earnings announcement on Wednesday, February 23rd 2022.
View our earnings forecast for CareDx.

How were CareDx's earnings last quarter?

CareDx, Inc (NASDAQ:CDNA) issued its quarterly earnings results on Thursday, October, 28th. The company reported $0.07 EPS for the quarter, topping the consensus estimate of ($0.14) by $0.21. The company earned $75.60 million during the quarter, compared to the consensus estimate of $74.11 million. CareDx had a negative trailing twelve-month return on equity of 4.24% and a negative net margin of 6.54%. The business's quarterly revenue was up 41.6% on a year-over-year basis. During the same quarter last year, the firm earned ($0.06) earnings per share.
View CareDx's earnings history.

What guidance has CareDx issued on next quarter's earnings?

CareDx updated its FY 2021 earnings guidance on Thursday, November, 4th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $290 million-$293 million, compared to the consensus revenue estimate of $290.39 million.

What price target have analysts set for CDNA?

6 equities research analysts have issued 12-month price objectives for CareDx's shares. Their forecasts range from $90.00 to $110.00. On average, they expect CareDx's share price to reach $97.60 in the next year. This suggests a possible upside of 120.8% from the stock's current price.
View analysts' price targets for CareDx or view top-rated stocks among Wall Street analysts.

Who are CareDx's key executives?

CareDx's management team includes the following people:

• Reginald Seeto, President, Chief Executive Officer & Director (LinkedIn Profile)
• Paul Ciccolella, Senior Vice President-Global Operations
• Ankur Dhingra, Chief Financial & Accounting Officer
• Amitabh Shukla, Senior Vice President-Technology
• Sham Dholakia, Senior VP-Medical Affairs & Clinical Operations

Who are some of CareDx's key competitors?

Some companies that are related to CareDx include Natera (NTRA), Elekta AB (publ) (EKTAY), Invitae (NVTA), Veracyte (VCYT), Fulgent Genetics (FLGT), RadNet (RDNT), Burning Rock Biotech (BNR), Castle Biosciences (CSTL), Genetron (GTH), Personalis (PSNL), Renalytix AI (RNLX), DermTech (DMTK), Viridian Therapeutics (VRDN), Progenity (PROG) and Sera Prognostics (SERA).
View all of CDNA's competitors.

What other stocks do shareholders of CareDx own?

Based on aggregate information from My MarketBeat watchlists, some companies that other CareDx investors own include Square (SQ), Roku (ROKU), Exact Sciences (EXAS), NVIDIA (NVDA), Advanced Micro Devices (AMD), Tesla (TSLA), Enphase Energy (ENPH), Johnson & Johnson (JNJ), Activision Blizzard (ATVI) and Alibaba Group (BABA).

What is CareDx's stock symbol?

CareDx trades on the NASDAQ under the ticker symbol "CDNA."

Who are CareDx's major shareholders?

CareDx's stock is owned by a number of retail and institutional investors. Top institutional investors include BlackRock Inc. (7.66%), Invesco Ltd. (5.68%), Matrix Capital Management Company LP (3.30%), Macquarie Group Ltd. (3.10%), Sumitomo Mitsui Trust Holdings Inc. (2.08%) and Nikko Asset Management Americas Inc. (2.07%). Company insiders that own CareDx stock include Ankur Dhingra, George Bickerstaff, Michael Brian Bell, Michael Goldberg, Paul Adler, Peter Maag, Ralph Snyderman, Reginald Seeto, Sasha King, Thomas A Thomas and William A Hagstrom.
View institutional ownership trends for CareDx.

Which institutional investors are selling CareDx stock?

CDNA stock was sold by a variety of institutional investors in the last quarter, including Goldman Sachs Group Inc., Millennium Management LLC, BlackRock Inc., PEAK6 Investments LLC, Next Century Growth Investors LLC, Bellevue Group AG, Sumitomo Mitsui Trust Holdings Inc., and Nikko Asset Management Americas Inc.. Company insiders that have sold CareDx company stock in the last year include George Bickerstaff, Michael Goldberg, Paul Adler, Peter Maag, Ralph Snyderman, Reginald Seeto, Sasha King, Thomas A Thomas, and William A Hagstrom.
View insider buying and selling activity for CareDx or view top insider-selling stocks.

Which institutional investors are buying CareDx stock?

CDNA stock was bought by a variety of institutional investors in the last quarter, including Conestoga Capital Advisors LLC, Blue Water Life Science Advisors LLC, Morgan Stanley, Renaissance Technologies LLC, ArrowMark Colorado Holdings LLC, Macquarie Group Ltd., Nordea Investment Management AB, and Two Sigma Investments LP.
View insider buying and selling activity for CareDx or or view top insider-buying stocks.

How do I buy shares of CareDx?

Shares of CDNA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is CareDx's stock price today?

One share of CDNA stock can currently be purchased for approximately $44.20.

How much money does CareDx make?

CareDx has a market capitalization of $2.33 billion and generates $192.19 million in revenue each year. The company earns $-18.71 million in net income (profit) each year or ($0.35) on an earnings per share basis.

How many employees does CareDx have?

CareDx employs 466 workers across the globe.

What is CareDx's official website?

The official website for CareDx is www.caredxinc.com.

Where are CareDx's headquarters?

CareDx is headquartered at 1 TOWER PLACE 9TH FLOOR, SOUTH SAN FRANCISCO CA, 94080.

How can I contact CareDx?

CareDx's mailing address is 1 TOWER PLACE 9TH FLOOR, SOUTH SAN FRANCISCO CA, 94080. The company can be reached via phone at (415) 287-2300, via email at [email protected], or via fax at 415-287-2450.